Australia - English - Department of Health (Therapeutic Goods Administration)

ausway pharmaceutical pty ltd - docosahexaenoic acid (dha)-rich oil derived from microalgae schizochytrium sp., quantity: 315 mg (equivalent: docosahexaenoic acid, qty 110.25 mg) - capsule, soft - excipient ingredients: lemon oil; lime oil distilled; soya oil; purified water; orange oil; gelatin; glycerol - maintain/support healthy eye function ; maintain/support general health and wellbeing ; maintain/support cardiovascular system health ; maintain/support cognitive function/mental function ; maintain/support brain function ; maintain/support brain/central nervous system development

Australia - English - Department of Health (Therapeutic Goods Administration)

leading advance group pty ltd - docosahexaenoic acid (dha)-rich oil derived from microalgae schizochytrium sp., quantity: 315 mg (equivalent: docosahexaenoic acid, qty 110.25 mg) - capsule, soft - excipient ingredients: lemon oil; gelatin; soya oil; glycerol; orange oil; purified water; lime oil distilled - helps maintain/support healthy eye development ; maintain/support healthy eyesight/vision ; maintain/support cardiovascular system health ; maintain/support brain/central nervous system development

Australia - English - Department of Health (Therapeutic Goods Administration)

the better health company (australia) pty - docosahexaenoic acid (dha)-rich oil derived from microalgae schizochytrium sp. -

Australia - English - Department of Health (Therapeutic Goods Administration)

the better health company (australia) pty - docosahexaenoic acid (dha)-rich oil derived from microalgae schizochytrium sp. -

Australia - English - Department of Health (Therapeutic Goods Administration)

swisse wellness pty ltd - docosahexaenoic acid (dha)-rich oil derived from microalgae schizochytrium sp. -

Australia - English - Department of Health (Therapeutic Goods Administration)

jbx pty ltd - docosahexaenoic acid (dha)-rich oil derived from microalgae schizochytrium sp., quantity: 525 mg (equivalent: docosahexaenoic acid, qty 210 mg) - capsule, soft - excipient ingredients: glycerol; purified water; gelatin - helps maintain/support healthy eye development ; helps maintain/support healthy vision development ; helps maintains/support healthy foetal cns/brain development ; maintain/support healthy pregnancy ; maintain/support maternal health

Australia - English - Department of Health (Therapeutic Goods Administration)

h c l manufacturers pty ltd - linseed oil, quantity: 214 mg; docosahexaenoic acid (dha)-rich oil derived from microalgae schizochytrium sp., quantity: 235.95 mg - capsule, soft - excipient ingredients: glycerol; gelatin; purified water; sunflower oil; ascorbyl palmitate; mixed (low-alpha type) tocopherols concentrate; rosmarinus officinalis; lecithin - maintain/support eye health ; maintain/support healthy eyesight/vision ; maintain/support healthy growth and development ; maintain/support general health and wellbeing ; maintain/support joint health ; maintain/support heart health ; maintain/support brain function ; maintain/support brain/central nervous system development ; maintains/support healthy foetal development ; maintain/support skin health

Australia - English - Department of Health (Therapeutic Goods Administration)

australia cobayer health food co pty ltd - docosahexaenoic acid (dha)-rich oil derived from microalgae schizochytrium sp. -

Australia - English - Department of Health (Therapeutic Goods Administration)

aussia pharma - docosahexaenoic acid (dha)-rich oil derived from microalgae schizochytrium sp. -

Australia - English - Department of Health (Therapeutic Goods Administration)

star combo australia pty ltd - docosahexaenoic acid (dha)-rich oil derived from microalgae schizochytrium sp., quantity: 250 mg (equivalent: docosahexaenoic acid, qty 100 mg) - capsule, soft - excipient ingredients: - maintain/support eye health ; helps maintain/support healthy heart function ; maintain/support brain health ; maintain/support nervous system health ; maintain/support brain/central nervous system development